How patient insight can transform advanced therapy development. Experts discuss embedding patient perspectives into trial design, endpoints and access.

A live Bio2Bedside podcast exploring right-to-try legislation, rare disease access and how biotech leaders can use emerging policies responsibly.

AI is transforming CGT research. Experts explore predictive modelling, experimental design and data-driven tools accelerating discovery and development.

How geopolitics is reshaping advanced therapies. Experts examine global funding shifts, APAC growth and the impact on supply chains, regulation and access.

Collaboration powers progress in advanced therapies. Experts explore partnership models that align academia, biotech and investors to accelerate innovation.

How do CGT teams scale from discovery to GMP manufacturing? Experts explore tech transfer strategies, scalability challenges and maintaining quality.

What actually moved advanced therapies forward in 2025? Leaders examine what worked, what didn’t and the realities shaping CGT in 2026.

A powerful patient story from Luke Keller, founder of Mighty Oaks Foundation, sharing his family’s CAR-T journey and why this work matters. A session to officially open Advanced Therapies Week 2026.